Tag Archives: kalydeco

October, 2018

August, 2018

December, 2017

August, 2017

May, 2017

March, 2017

December, 2016

October, 2016

February, 2016

May, 2015

  • 12 May

    FDA Panel Recommends Approval of Vertex’s Cystic Fibrosis Combo

    A US Food and Drug Administration (FDA) advisory committee has recommended approval of Vertex Pharmaceuticals’ new combination therapy for treatment of cystic fibrosis (CF). The agency’s Pulmonary-Allergy Drugs Advisory Committee voted 12 to 1 in favor of approving the drug, which consists of Vertex’s already approved drug Kalydeco (ivacaftor) and …